Compounds > isomethyleugenol
Page last updated: 2024-08-18

isomethyleugenol and Intradural-Extramedullary Spinal Cord Neoplasms

isomethyleugenol has been researched along with Intradural-Extramedullary Spinal Cord Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hatanaka, KC; Hida, K; Ishi, Y; Ishida, Y; Oda, Y; Seki, T; Takamiya, S; Tanaka, S; Yamaguchi, S; Yamazaki, K1

Other Studies

1 other study(ies) available for isomethyleugenol and Intradural-Extramedullary Spinal Cord Neoplasms

ArticleYear
Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas.
    Brain tumor pathology, 2020, Volume: 37, Issue:3

    Topics: Enhancer of Zeste Homolog 2 Protein; Gene Expression; Glioma; Histones; Humans; Methylation; Mutation, Missense; Prognosis; Retrospective Studies; Spinal Cord Neoplasms

2020